Media

Corporate Presentations:
December 2009	Company Overview
December 2009	Descripción de la Empresa
Press Releases and Articles:
10/20/2009	TechnoVax Receives $2.9 Million Grant for Flu and Influenza Virus-Like Particle (VLP) Vaccine Program
07/18/2007	TechnoVax Reports on a VLP Vaccine Designed to Protect Against the Devastating 1918 Pandemic Influenza As Well As a Novel Bivalent VLP Vaccine Candidate
12/11/2006	TechnoVax Licenses Wyeth's Virus-Like Particle Vaccine Technology.
05/01/2006	MIT - Technology Review: As it tests a new way of making vaccines, TechnoVax is targeting the deadly 1918 flu virus.
05/01/2006	MIT - Technology Review: Catching the Flu: A Photo Essay.
Publications:
Viral Immunology	A Novel Intranasal Virus-Like Particle (VLP) Vaccine Designed to Protect against the Pandemic 1918 Influenza A Virus (H1N1). 2007
	Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge. 2005
Journal of Virology	Formation of Wild-Type and Chimeric Influenza Virus-Like Particles following Simultaneous Expression of Only Four Structural Proteins. 2001

Copyright © 2003-2009 TechnoVax. All rights reserved.   •   Website by AJ Network Solutions